Treatment Options: Finding Your Path to Remission

Because Pemphigus Herpetiformis (PH) is a rare and unique variant, there is no single “perfect” treatment algorithm that works for everyone ^[1]. Instead, doctors tailor your care by balancing the need to stop the immune system’s attack with the goal of minimizing the side effects of long-term medication ^[2].

Crucial Warning: Never start, stop, or rapidly taper prednisone or other systemic immunosuppressants without medical supervision.

Controlling the Initial Flare

The first priority in treating PH is to achieve remission, or clear skin. For patients with more extensive disease, this often requires systemic corticosteroids (such as prednisone or methylprednisolone) ^[1]. Limited disease may be managed with potent topical corticosteroids.

In clinical reviews, many patients with PH initially require these high-dose steroids to gain control over the blistering and intense itching ^[1][2]. While steroids are highly effective and can lead to rapid resolution, their response time and treatment duration vary ^[3][2]. They are generally not used as a long-term solution because of the risk of complications like infection, bone thinning, and high blood sugar.

Steroid-Sparing Options

To help lower your steroid dose, your doctor will likely introduce steroid-sparing agents. These medications allow the doctor to “taper” or reduce your steroid dose while still keeping the disease in check ^[4]. Steroid-sparing therapy may be introduced concurrently rather than only after control.

• Dapsone: This is often considered a key therapy for PH, partly because it is excellent at reducing the intense itching (pruritus) ^[1]. However, response to dapsone is heterogeneous, meaning it varies widely between patients ^[5]. Some people achieve complete remission with dapsone alone, while others find it ineffective unless paired with steroids ^[2][6]. Safety check: Dapsone requires baseline testing for G6PD (deficiency increases the risk of oxidative hemolysis), and monitoring for hemolytic anemia, methemoglobinemia, agranulocytosis, and severe rash or liver injury. Note that a prior “sulfa” allergy does not automatically predict cross-reactivity with dapsone, but all prior serious drug reactions require clinician review.
• Sulfasalazine: Like dapsone, this drug has been used with success in small groups of PH patients, providing at least partial control of the disease ^[1][7].
• Azathioprine: This is a classic immunosuppressant often used alongside steroids to help maintain remission ^[1][5]. Safety check: Requires baseline TPMT/NUDT15 consideration and regular CBC/liver monitoring.
• Mycophenolate Mofetil (MMF): This is another option for patients who do not respond well to dapsone. Individual case reports have shown “excellent clinical responses” with MMF, even in cases where other treatments have failed ^[8][9]. Safety check: Has major pregnancy precautions and requires infection monitoring (CBC/liver tests).

The Nuance of Rituximab in PH

If you research pemphigus online, you will likely see a lot of information about Rituximab, a biological therapy that is an established option—and often guideline-supported—for moderate-to-severe Pemphigus Vulgaris ^[10]. However, the exact role of Rituximab in the herpetiformis variant is much less certain because evidence is sparse.

Research suggests that Rituximab may be considered off-label and individualized for PH. In one small study of eight PH patients, Rituximab was found to be ineffective in some cases ^[1]. Because PH can involve different antibodies (like those targeting desmocollins), it may not always respond to the same approach used for other variants, and its use depends on clinician judgment ^[1][11]. Safety check: Requires hepatitis B screening, specific vaccination timing, and monitoring for infusion reactions and hypogammaglobulinemia.

Managing Your Long-Term Care

PH is a chronic condition, and relapses are common; one study found that a majority of patients experienced a flare-up during long-term follow-up ^[2].

Because there is no single established dosing or tapering schedule just for PH, your treatment must be individualized ^[12]. Your care team will monitor you closely for both disease activity and treatment side effects, such as cutaneous infections, which have been reported in patients during therapy ^[2]. Regular blood work and skin checks are the best ways to ensure your treatment plan remains safe and effective over time.